FIELD: medicine.
SUBSTANCE: patient is interviewed and undergoes biochemical tests and ultrasonic examination. That is followed by fibrogastroduodenoscopy involving parapapillary block within a duodenal papilla at 10 mm from the mouth and formation of a first submucosal depot of 0.5% Novocaine 10 ml and 4% gentamycin 2 ml in the 9 o'clock position. In the 15 o'clock position, a second submucosal depot of 2% drotaverin 2 ml and 1% dimedrol 2 ml is formed. If observing pain management for 10 minutes, the mild clinical course of acute biliary pancreatitis is diagnosed, whereas no pain management enables diagnosing the severe clinical course of acute biliary pancreatitis.
EFFECT: method provides the adequate assessment of the severity of acute biliary pancreatitis for the 24 hours following the admission to hospital with underlying therapeutic measures.
1 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PREVENTION AND TREATMENT OF REACTIVE PANCREATITIS | 2006 |
|
RU2324480C2 |
METHOD FOR PREVENTION OF ACUTE POSTMANIPULATORY PANCREATITIS | 2021 |
|
RU2779221C1 |
METHOD FOR EARLY THERAPY OF ACUTE PANCREATITIS | 2016 |
|
RU2632448C1 |
METHOD OF TREATING PAIN SYNDROME ACCOMPANYING PANCREATITIS | 2012 |
|
RU2517163C2 |
METHOD OF PREVENTING ACUTE POSTOPERATIVE PANCREATITIS | 2012 |
|
RU2517210C2 |
METHOD FOR DIFFERENTIAL DIAGNOSIS OF STERILE AND INFECTED PANCREATITIS | 2022 |
|
RU2793647C1 |
METHOD FOR PREVENTION OF INFECTIOUS COMPLICATIONS IN ACUTE DESTRUCTIVE PANCREATITIS | 2017 |
|
RU2672592C1 |
METHOD FOR DETERMINING SEVERITY LEVEL OF ACUTE PANCREATITIS | 2010 |
|
RU2453841C2 |
METHOD FOR DETERMINING EFFECTIVENESS OF ADMINISTERED ANTI-PANCREATIC THERAPY | 2012 |
|
RU2520658C1 |
METHOD OF PARAPANCREATIC BLOCKADES | 2010 |
|
RU2454935C2 |
Authors
Dates
2015-04-20—Published
2014-06-10—Filed